Needle-Free Drug Delivery Systems-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Needle-Free Drug Delivery Systems-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Needle-Free Drug Delivery Systems industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Needle-Free Drug Delivery Systems 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Needle-Free Drug Delivery Systems worldwide and market share by regions, with company and product introduction, position in the Needle-Free Drug Delivery Systems market
Market status and development trend of Needle-Free Drug Delivery Systems by types and applications
Cost and profit status of Needle-Free Drug Delivery Systems, and marketing status
Market growth drivers and challenges
The report segments the global Needle-Free Drug Delivery Systems market as:
Global Needle-Free Drug Delivery Systems Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Needle-Free Drug Delivery Systems Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
Global Needle-Free Drug Delivery Systems Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
Global Needle-Free Drug Delivery Systems Market: Manufacturers Segment Analysis (Company and Product introduction, Needle-Free Drug Delivery Systems Sales Volume, Revenue, Price and Gross Margin):
3M Pharmaceuticals
Pharmajet, Inc
Injex Pharma AG
Antares Pharma, Inc.
Crossject SA
BD (
Becton Dickinson)
MedImmune, Inc
Mystic Pharmaceuticals, Inc
Optinose, Inc
Valeritas, Inc
Zogenix, Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Needle-Free Drug Delivery Systems-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Needle-Free Drug Delivery Systems industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Needle-Free Drug Delivery Systems 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Needle-Free Drug Delivery Systems worldwide and market share by regions, with company and product introduction, position in the Needle-Free Drug Delivery Systems market
Market status and development trend of Needle-Free Drug Delivery Systems by types and applications
Cost and profit status of Needle-Free Drug Delivery Systems, and marketing status
Market growth drivers and challenges
The report segments the global Needle-Free Drug Delivery Systems market as:
Global Needle-Free Drug Delivery Systems Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Needle-Free Drug Delivery Systems Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
Global Needle-Free Drug Delivery Systems Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
Global Needle-Free Drug Delivery Systems Market: Manufacturers Segment Analysis (Company and Product introduction, Needle-Free Drug Delivery Systems Sales Volume, Revenue, Price and Gross Margin):
3M Pharmaceuticals
Pharmajet, Inc
Injex Pharma AG
Antares Pharma, Inc.
Crossject SA
BD (
Becton Dickinson)
MedImmune, Inc
Mystic Pharmaceuticals, Inc
Optinose, Inc
Valeritas, Inc
Zogenix, Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
1.1 Definition of Needle-Free Drug Delivery Systems in This Report
1.2 Commercial Types of Needle-Free Drug Delivery Systems
1.2.1 Jet-based Needle-free Injectors
1.2.2 Spring-based Needle-free Injectors
1.2.3 Laser-based Needle-free Injectors
1.3 Downstream Application of Needle-Free Drug Delivery Systems
1.3.1 Insulin Needle-free Drug Delivery
1.3.2 Vaccine Needle-free Drug Delivery
1.3.3 Pediatric Needle-free Drug Delivery
1.3.4 Pain Needle-free Drug Delivery
1.3.5 Other Needle-free Drug Delivery
1.4 Development History of Needle-Free Drug Delivery Systems
1.5 Market Status and Trend of Needle-Free Drug Delivery Systems 2013-2023
1.5.1 Global Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
1.5.2 Regional Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Needle-Free Drug Delivery Systems 2013-2017
2.2 Sales Market of Needle-Free Drug Delivery Systems by Regions
2.2.1 Sales Volume of Needle-Free Drug Delivery Systems by Regions
2.2.2 Sales Value of Needle-Free Drug Delivery Systems by Regions
2.3 Production Market of Needle-Free Drug Delivery Systems by Regions
2.4 Global Market Forecast of Needle-Free Drug Delivery Systems 2018-2023
2.4.1 Global Market Forecast of Needle-Free Drug Delivery Systems 2018-2023
2.4.2 Market Forecast of Needle-Free Drug Delivery Systems by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Needle-Free Drug Delivery Systems by Types
3.2 Sales Value of Needle-Free Drug Delivery Systems by Types
3.3 Market Forecast of Needle-Free Drug Delivery Systems by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Needle-Free Drug Delivery Systems by Downstream Industry
4.2 Global Market Forecast of Needle-Free Drug Delivery Systems by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Needle-Free Drug Delivery Systems Market Status by Countries
5.1.1 North America Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
5.1.2 North America Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
5.1.3 United States Needle-Free Drug Delivery Systems Market Status (2013-2017)
5.1.4 Canada Needle-Free Drug Delivery Systems Market Status (2013-2017)
5.1.5 Mexico Needle-Free Drug Delivery Systems Market Status (2013-2017)
5.2 North America Needle-Free Drug Delivery Systems Market Status by Manufacturers
5.3 North America Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
5.3.1 North America Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
5.3.2 North America Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
5.4 North America Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Needle-Free Drug Delivery Systems Market Status by Countries
6.1.1 Europe Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
6.1.2 Europe Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
6.1.3 Germany Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.4 UK Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.5 France Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.6 Italy Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.7 Russia Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.8 Spain Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.9 Benelux Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.2 Europe Needle-Free Drug Delivery Systems Market Status by Manufacturers
6.3 Europe Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
6.3.1 Europe Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
6.3.2 Europe Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
6.4 Europe Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Countries
7.1.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
7.1.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
7.1.3 China Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.4 Japan Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.5 India Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.6 Southeast Asia Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.7 Australia Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.2 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Manufacturers
7.3 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
7.3.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
7.3.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
7.4 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Needle-Free Drug Delivery Systems Market Status by Countries
8.1.1 Latin America Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
8.1.2 Latin America Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
8.1.3 Brazil Needle-Free Drug Delivery Systems Market Status (2013-2017)
8.1.4 Argentina Needle-Free Drug Delivery Systems Market Status (2013-2017)
8.1.5 Colombia Needle-Free Drug Delivery Systems Market Status (2013-2017)
8.2 Latin America Needle-Free Drug Delivery Systems Market Status by Manufacturers
8.3 Latin America Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
8.3.1 Latin America Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
8.3.2 Latin America Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
8.4 Latin America Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Countries
9.1.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
9.1.3 Middle East Needle-Free Drug Delivery Systems Market Status (2013-2017)
9.1.4 Africa Needle-Free Drug Delivery Systems Market Status (2013-2017)
9.2 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Manufacturers
9.3 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
9.3.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
9.4 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
10.1 Global Economy Situation and Trend Overview
10.2 Needle-Free Drug Delivery Systems Downstream Industry Situation and Trend Overview
CHAPTER 11 NEEDLE-FREE DRUG DELIVERY SYSTEMS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Needle-Free Drug Delivery Systems by Major Manufacturers
11.2 Production Value of Needle-Free Drug Delivery Systems by Major Manufacturers
11.3 Basic Information of Needle-Free Drug Delivery Systems by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Needle-Free Drug Delivery Systems Major Manufacturer
11.3.2 Employees and Revenue Level of Needle-Free Drug Delivery Systems Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NEEDLE-FREE DRUG DELIVERY SYSTEMS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 3M Pharmaceuticals
12.1.1 Company profile
12.1.2 Representative Needle-Free Drug Delivery Systems Product
12.1.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M Pharmaceuticals
12.2 Pharmajet, Inc
12.2.1 Company profile
12.2.2 Representative Needle-Free Drug Delivery Systems Product
12.2.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Pharmajet, Inc
12.3 Injex Pharma AG
12.3.1 Company profile
12.3.2 Representative Needle-Free Drug Delivery Systems Product
12.3.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Injex Pharma AG
12.4 Antares Pharma, Inc.
12.4.1 Company profile
12.4.2 Representative Needle-Free Drug Delivery Systems Product
12.4.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Antares Pharma, Inc.
12.5 Crossject SA
12.5.1 Company profile
12.5.2 Representative Needle-Free Drug Delivery Systems Product
12.5.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Crossject SA
12.6 BD (
12.6.1 Company profile
12.6.2 Representative Needle-Free Drug Delivery Systems Product
12.6.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of BD (
12.7 Becton Dickinson)
12.7.1 Company profile
12.7.2 Representative Needle-Free Drug Delivery Systems Product
12.7.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Becton Dickinson)
12.8 MedImmune, Inc
12.8.1 Company profile
12.8.2 Representative Needle-Free Drug Delivery Systems Product
12.8.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of MedImmune, Inc
12.9 Mystic Pharmaceuticals, Inc
12.9.1 Company profile
12.9.2 Representative Needle-Free Drug Delivery Systems Product
12.9.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Mystic Pharmaceuticals, Inc
12.10 Optinose, Inc
12.10.1 Company profile
12.10.2 Representative Needle-Free Drug Delivery Systems Product
12.10.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Optinose, Inc
12.11 Valeritas, Inc
12.11.1 Company profile
12.11.2 Representative Needle-Free Drug Delivery Systems Product
12.11.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Valeritas, Inc
12.12 Zogenix, Inc
12.12.1 Company profile
12.12.2 Representative Needle-Free Drug Delivery Systems Product
12.12.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Zogenix, Inc
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
13.1 Industry Chain of Needle-Free Drug Delivery Systems
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
14.1 Cost Structure Analysis of Needle-Free Drug Delivery Systems
14.2 Raw Materials Cost Analysis of Needle-Free Drug Delivery Systems
14.3 Labor Cost Analysis of Needle-Free Drug Delivery Systems
14.4 Manufacturing Expenses Analysis of Needle-Free Drug Delivery Systems
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Needle-Free Drug Delivery Systems in This Report
1.2 Commercial Types of Needle-Free Drug Delivery Systems
1.2.1 Jet-based Needle-free Injectors
1.2.2 Spring-based Needle-free Injectors
1.2.3 Laser-based Needle-free Injectors
1.3 Downstream Application of Needle-Free Drug Delivery Systems
1.3.1 Insulin Needle-free Drug Delivery
1.3.2 Vaccine Needle-free Drug Delivery
1.3.3 Pediatric Needle-free Drug Delivery
1.3.4 Pain Needle-free Drug Delivery
1.3.5 Other Needle-free Drug Delivery
1.4 Development History of Needle-Free Drug Delivery Systems
1.5 Market Status and Trend of Needle-Free Drug Delivery Systems 2013-2023
1.5.1 Global Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
1.5.2 Regional Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Needle-Free Drug Delivery Systems 2013-2017
2.2 Sales Market of Needle-Free Drug Delivery Systems by Regions
2.2.1 Sales Volume of Needle-Free Drug Delivery Systems by Regions
2.2.2 Sales Value of Needle-Free Drug Delivery Systems by Regions
2.3 Production Market of Needle-Free Drug Delivery Systems by Regions
2.4 Global Market Forecast of Needle-Free Drug Delivery Systems 2018-2023
2.4.1 Global Market Forecast of Needle-Free Drug Delivery Systems 2018-2023
2.4.2 Market Forecast of Needle-Free Drug Delivery Systems by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Needle-Free Drug Delivery Systems by Types
3.2 Sales Value of Needle-Free Drug Delivery Systems by Types
3.3 Market Forecast of Needle-Free Drug Delivery Systems by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Needle-Free Drug Delivery Systems by Downstream Industry
4.2 Global Market Forecast of Needle-Free Drug Delivery Systems by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Needle-Free Drug Delivery Systems Market Status by Countries
5.1.1 North America Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
5.1.2 North America Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
5.1.3 United States Needle-Free Drug Delivery Systems Market Status (2013-2017)
5.1.4 Canada Needle-Free Drug Delivery Systems Market Status (2013-2017)
5.1.5 Mexico Needle-Free Drug Delivery Systems Market Status (2013-2017)
5.2 North America Needle-Free Drug Delivery Systems Market Status by Manufacturers
5.3 North America Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
5.3.1 North America Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
5.3.2 North America Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
5.4 North America Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Needle-Free Drug Delivery Systems Market Status by Countries
6.1.1 Europe Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
6.1.2 Europe Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
6.1.3 Germany Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.4 UK Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.5 France Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.6 Italy Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.7 Russia Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.8 Spain Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.1.9 Benelux Needle-Free Drug Delivery Systems Market Status (2013-2017)
6.2 Europe Needle-Free Drug Delivery Systems Market Status by Manufacturers
6.3 Europe Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
6.3.1 Europe Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
6.3.2 Europe Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
6.4 Europe Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Countries
7.1.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
7.1.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
7.1.3 China Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.4 Japan Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.5 India Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.6 Southeast Asia Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.1.7 Australia Needle-Free Drug Delivery Systems Market Status (2013-2017)
7.2 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Manufacturers
7.3 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
7.3.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
7.3.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
7.4 Asia Pacific Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Needle-Free Drug Delivery Systems Market Status by Countries
8.1.1 Latin America Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
8.1.2 Latin America Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
8.1.3 Brazil Needle-Free Drug Delivery Systems Market Status (2013-2017)
8.1.4 Argentina Needle-Free Drug Delivery Systems Market Status (2013-2017)
8.1.5 Colombia Needle-Free Drug Delivery Systems Market Status (2013-2017)
8.2 Latin America Needle-Free Drug Delivery Systems Market Status by Manufacturers
8.3 Latin America Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
8.3.1 Latin America Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
8.3.2 Latin America Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
8.4 Latin America Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Countries
9.1.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Countries (2013-2017)
9.1.3 Middle East Needle-Free Drug Delivery Systems Market Status (2013-2017)
9.1.4 Africa Needle-Free Drug Delivery Systems Market Status (2013-2017)
9.2 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Manufacturers
9.3 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Type (2013-2017)
9.3.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Type (2013-2017)
9.4 Middle East and Africa Needle-Free Drug Delivery Systems Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
10.1 Global Economy Situation and Trend Overview
10.2 Needle-Free Drug Delivery Systems Downstream Industry Situation and Trend Overview
CHAPTER 11 NEEDLE-FREE DRUG DELIVERY SYSTEMS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Needle-Free Drug Delivery Systems by Major Manufacturers
11.2 Production Value of Needle-Free Drug Delivery Systems by Major Manufacturers
11.3 Basic Information of Needle-Free Drug Delivery Systems by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Needle-Free Drug Delivery Systems Major Manufacturer
11.3.2 Employees and Revenue Level of Needle-Free Drug Delivery Systems Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 NEEDLE-FREE DRUG DELIVERY SYSTEMS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 3M Pharmaceuticals
12.1.1 Company profile
12.1.2 Representative Needle-Free Drug Delivery Systems Product
12.1.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M Pharmaceuticals
12.2 Pharmajet, Inc
12.2.1 Company profile
12.2.2 Representative Needle-Free Drug Delivery Systems Product
12.2.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Pharmajet, Inc
12.3 Injex Pharma AG
12.3.1 Company profile
12.3.2 Representative Needle-Free Drug Delivery Systems Product
12.3.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Injex Pharma AG
12.4 Antares Pharma, Inc.
12.4.1 Company profile
12.4.2 Representative Needle-Free Drug Delivery Systems Product
12.4.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Antares Pharma, Inc.
12.5 Crossject SA
12.5.1 Company profile
12.5.2 Representative Needle-Free Drug Delivery Systems Product
12.5.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Crossject SA
12.6 BD (
12.6.1 Company profile
12.6.2 Representative Needle-Free Drug Delivery Systems Product
12.6.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of BD (
12.7 Becton Dickinson)
12.7.1 Company profile
12.7.2 Representative Needle-Free Drug Delivery Systems Product
12.7.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Becton Dickinson)
12.8 MedImmune, Inc
12.8.1 Company profile
12.8.2 Representative Needle-Free Drug Delivery Systems Product
12.8.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of MedImmune, Inc
12.9 Mystic Pharmaceuticals, Inc
12.9.1 Company profile
12.9.2 Representative Needle-Free Drug Delivery Systems Product
12.9.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Mystic Pharmaceuticals, Inc
12.10 Optinose, Inc
12.10.1 Company profile
12.10.2 Representative Needle-Free Drug Delivery Systems Product
12.10.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Optinose, Inc
12.11 Valeritas, Inc
12.11.1 Company profile
12.11.2 Representative Needle-Free Drug Delivery Systems Product
12.11.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Valeritas, Inc
12.12 Zogenix, Inc
12.12.1 Company profile
12.12.2 Representative Needle-Free Drug Delivery Systems Product
12.12.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Zogenix, Inc
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
13.1 Industry Chain of Needle-Free Drug Delivery Systems
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
14.1 Cost Structure Analysis of Needle-Free Drug Delivery Systems
14.2 Raw Materials Cost Analysis of Needle-Free Drug Delivery Systems
14.3 Labor Cost Analysis of Needle-Free Drug Delivery Systems
14.4 Manufacturing Expenses Analysis of Needle-Free Drug Delivery Systems
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
